Arxis, Inc. has filed a prospectus supplement to provide updated information regarding its recent merger with Omnetics Connector Corporation. This filing is crucial for investors as it outlines the details of the transaction, which is expected to significantly impact Arxis's growth and market presence.
Arxis, Inc., incorporated in Delaware, operates in the Aircraft Parts & Auxiliary Equipment industry (SIC: 3728). The company trades on the Nasdaq under the ticker symbol ARXS. Recent filings include a Form 424B3, dated October 29, 2026, and a Form 8-K/A, which was also filed on the same day. These filings reflect the company's ongoing efforts to keep investors informed about its strategic initiatives.
The latest filing states, "This Prospectus Supplement No. 2 supplements the prospectus dated October 22, 2026, which forms a part of our Registration Statement on Form S-1 (Registration Statement No. 333-299412)." This supplement is particularly important as it details the issuance of 13,351,964 shares of Arxis Class A common stock as part of the merger transaction.
The merger, which was finalized on August 17, 2026, involved an aggregate consideration based on an enterprise value of $770 million, subject to customary closing adjustments. Arxis issued shares to the former shareholders of Omnetics and funded $8 million into cash escrow accounts as part of the agreement.
This merger is expected to affect various stakeholders, including shareholders of both Arxis and Omnetics, as well as employees and customers of the newly combined entity. The transaction may enhance Arxis's competitive position in the aircraft parts industry, allowing it to leverage Omnetics's existing capabilities and market presence.
Looking ahead, further updates may be provided through additional filings as Arxis integrates Omnetics into its operations. The filing does not specify what happens next but indicates that the company is committed to keeping its investors informed about ongoing developments.
Read Next
Aspen Neuroscience reports major stock transactions by director
Aspen Neuroscience Reports Major Stock Transactions by Investors
John P. Reed files to sell 179,020 shares of Arhaus, Inc.
Webull Corp Officer Files to Sell 107,692 Shares
Fermi Inc. files to sell 94,000 shares of common stock
ServiceTitan Officer Ara Mahdessian Files to Sell Shares









